Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

Not Applicable

Completed

• Conditions: Hepatitis C; Tobacco Use Cessation; Colon Cancer; Pneumonia, Bacterial; Lung Cancer; Obesity; Shingles
• Interventions: Other: Epic Healthy Planet Population Health Module

• Registration Number: NCT04540081
• Lead Sponsor: University of California, Davis

Brief Summary

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-08-31
• Study First Submitted QC: 2020-08-31
• Study First Posted: 2020-09-07
• Study Start: 2020-10-05
• Status Verified: 2021-11
• Primary Completion: 2022-10-05
• Study Completion: 2022-10-05
• Last Update Submitted: 2023-12-23
• Last Update Posted: 2023-12-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

• Any patient who has a UC Davis or UC Irvine primary care provider (PCP) and is deficient in any of the following: colon cancer screening, lung cancer screening, tobacco cessation counseling, obesity counseling, pneumonia vaccination, shingles vaccine, and hepatitis C screening.

Exclusion Criteria

• Patients outside of the age limits or have an established PCP.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
CLOVER arm	Epic Healthy Planet Population Health Module	This arm will contain clinics that utilize the CLOVER intervention

Primary Outcome Measures

Name	Time	Method
Overall Adherence to CLOVER Metrics	6 months	This is the proportion of patients who appropriately completed screenings and vaccinations that they were eligible for

Secondary Outcome Measures

Name	Time	Method
Shingles vaccination	6 months	Proportion of eligible patients who completed shingles vaccination.
Hepatitis C screening	6 months	Proportion of eligible patients who completed hepatitis C screening.
Obesity counseling	6 months	Proportion of eligible patients who completed obesity counseling.
Tobacco cessation counseling	6 months	Proportion of eligible patients who completed tobacco cessation counseling.
Colon cancer screening	6 months	Proportion of eligible patients who completed colon cancer screening.
Lung cancer screening	6 months	Proportion of eligible patients who completed lung cancer screening.
Pneumonia vaccination	6 months	Proportion of eligible patients who completed pneumonia vaccination.

Trial Locations

Locations (1)

UC Davis Medical Center; 🇺🇸 Sacramento, California, United States